key: cord-0065240-roezawtq
authors: Clemens, Jeffrey; Ippolito, Benedic; Veuger, Stan
title: Medicaid and fiscal federalism during the COVID‐19 pandemic
date: 2021-05-18
journal: nan
DOI: 10.1111/pbaf.12287
sha: a697fbe2649eeef0028702bce21274bf46546e2c
doc_id: 65240
cord_uid: roezawtq

We analyze the effects of the COVID‐19 pandemic on state and local government finances, with an emphasis on health spending needs and the role of the Medicaid program. We first find that enhanced federal matching funds are roughly the same size as expected increases in state Medicaid costs nationwide over the entirety of the federal budget window. Second, we show that there is substantial variation in states' exposure to increases in Medicaid program costs. Third, we show that the formulas through which fiscal relief has been distributed impact the extent to which aid targets the states experiencing the greatest need. Applications for Practice: –. During the COVID‐19 pandemic, states' Medicaid programs have been both a source of heightened expenditures and a vehicle through which federal aid has flowed. –. Nationwide, we find that enhanced federal Medicaid matching funds are roughly the same size as expected increases in states' Medicaid costs over the entirety of the federal budget window. –. We find that enhanced Medicaid matching funds are not correlated with variations in states' Medicaid enrollment increases and thus do not effectively target the states that have experienced the largest increases in program cost. –. We find that the American Rescue Plan Act's unemployment‐based formula for allocating federal dollars does a moderately better job than the enhanced Medicaid matching funds at targeting resources at states that have experienced the largest increases in Medicaid enrollment.

We analyze the effects of the COVID-19 pandemic on state and local government finances, with an emphasis on health spending needs and the role of the Medicaid program. We first find that enhanced federal matching funds are roughly the same size as expected increases in state Medicaid costs nationwide over the entirety of the federal budget window. Second, we show that there is substantial variation in states' exposure to increases in Medicaid program costs. Third, we show that the formulas through which fiscal relief has been distributed impact the extent to which aid targets the states experiencing the greatest need.

Applications for Practice -During the COVID-19 pandemic, states' Medicaid programs have been both a source of heightened expenditures and a vehicle through which federal aid has flowed. -Nationwide, we find that enhanced federal Medicaid matching funds are roughly the same size as expected increases in states' Medicaid costs over the entirety of the federal budget window. -We find that enhanced Medicaid matching funds are not correlated with variations in states' Medicaid enrollment increases and thus do not effectively target the states that have experienced the largest increases in program cost. -We find that the American Rescue Plan Act's unemployment-based formula for allocating federal dollars does a moderately better job than the enhanced Medicaid matching funds at targeting resources at states that have experienced the largest increases in Medicaid enrollment.

Our aim in this paper is to describe the fiscal challenges that confront state and local governments as a result of the COVID-19 pandemic, and the federal government's role in addressing them. As we have discussed elsewhere (Clemens & Veuger, 2020a) , challenges arise due to three factors. First, to varying degrees, state and local governments are constrained by balanced budget requirements. Second, the pandemic has adversely affected revenues. Third, the pandemic has increased certain expenditure needs. In this paper, we attempt to have a unified discussion of these issues, with an emphasis on health spending needs and the role of the Medicaid program. Taken together, state and local governments serve a broad set of functions. They administer and at least partially finance many public services, as well as major income-support programs. The services provided by state and local governments range from education to public safety and public utilities. In recent years, the delivery of these services had led state and local governments to employ just under 20 million workers (Shoag & Veuger, 2020) . This accounts for roughly 13% of all nonfarm employment.

The motivation for federal fiscal stabilization arises from state and local balanced-budget constraints. When state governments face downturns, their balanced budget rules prevent them from contributing to countercyclical policy and in fact force them to engage in procyclical policy. 1 As revenues decline and spending needs rise, compliance with balanced-budget rules dictates increases in tax rates and a search for budgetary savings. Savings may come from wage freezes and layoffs for members of the public-sector workforce. Figure 1 illustrates the reductions in state and local government employment that took place between January 2020 and February 2021. This can, in turn, imply reductions in service delivery just as needs run high.

Given the existence of states' balanced-budget requirements, it is not surprising that the federal government has a history of intervening to reduce states' fiscal stress. The 2009 American Recovery and Reinvestment Act (ARRA), which included $232 billion in support for state governments, is a prominent example (United States Bureau of Economic Analysis, 2020b). In the current crisis, federal support for state and local governments has come piecemeal through existing and new legislation discussed below. This support is of central importance to the US system of fiscal federalism, which is characterized by heavy reliance on the central fiscal authority for countercyclical policy. 2 In the next section, we summarize what is known about the COVID-19 pandemic's impacts on the revenues and expenditure needs of state and local governments. We also discuss the major provisions in federal legislation that have been enacted to support state and local government budgets. We then turn to the meat of the paper: a discussion of the role of the Medicaid and Children's Health Insurance Program (CHIP), which highlights the complex relationships between new spending needs, intergovernmental transfers, and the conditions on which the federal government makes its aid contingent. Medicaid is of particular importance in the current context for three reasons: it provides health insurance, which may be more important during a pandemic than in normal times; it provides a safety net for workers who have lost their employment, as so many did during the COVID-19 recession; and it was the channel through which the federal government provided some of its earliest financial support to the states, both through Medicaid's normal financing and by increasing the federal matching rate. It also provides us with a setting that lets us illustrate the heterogeneity across states in new spending needs. This allows us, in turn, to assess how effective federal aid has been in dealing with that heterogeneity.

We conclude the paper with a discussion of the conditions under which federal funding, for Medicaid in particular, is provided to state and local governments. We discuss the relevance of the timing and duration of federal aid flows, as well as the importance of uncertainty surrounding these parameters.

The COVID-19 crisis has changed the budgetary situation of US state and local governments through three main routes. These routes include changes in tax and other revenue, increases in spending needs, and increases inflows of federal aid.

Several analyses have undertaken the task of estimating the revenue shortfalls that are likely to face state and local governments over the current fiscal year. The preferred approach for projecting shortfalls makes use of forecasts for macroeconomic variables that are reasonably close proxies for major revenue bases. This is the approach taken in Clemens and Veuger (2020b) , Whitaker (2020a Whitaker ( , 2020b , Auerbach et al. (2020), and Chernick et al. (2020) . Following this basic approach, a recent estimate finds that the total revenue shortfall for state and local governments between April 2020 and June 2021 amounts to about $130 billion (Clemens & Veuger, 2021) . 3 The aggregate revenue shortfall across states masks significant heterogeneity. Across states, for example, Auerbach et al. (2020) estimate a loss of revenue, expressed as a share of ownsource revenue, excluding fees to hospitals and institutions of higher education, that ranges from 3.1% in Kansas to 9.6% in Nevada. This variation reflects, among other things, variation in state and local governments' reliance on different tax instruments as well as differences in the distribution of economic activity across sectors. A second factor to consider are the actions already taken by the federal government to support state and local government budgets. The federal government's initial response to the economic downturn triggered by the COVID-19 pandemic was swift and sizable. In March and April 2020, Congress and the executive branch passed a number of pieces of legislation that together provided trillions of dollars in relief. Auerbach et al. (2020) calculate that between the Families First Coronavirus Response Act (FFCRA), the Coronavirus Aid, Relief, and Economic Security (CARES) Act, and the Paycheck Protection Program and Health Care Enhancement (PPPHCE) Act, the federal government provided up to "$212 billion in aid to state and local governments, excluding aid to public hospitals and higher ed., and $250 billion including that aid" in 2020. If we add to that the relief funds for state and local governments included in the December 2020 Consolidated Appropriations Act of 2021, the overall number exceeds $300 billion (Clemens & Veuger, 2021 ; Committee for a Responsible Federal Budget, 2020). Finally, the American Rescue Plan Act (ARPA) of 2021, which became law in March 2021, contains well over $500 billion in additional funding directed at state and local governments (Committee for a Responsible Federal Budget, 2021a). In summary, total federal aid for state and local governments allocated so far is in excess of $800 billion, much of which will be allocated before the end of the 2021 fiscal year (Committee for a Responsible Federal Budget, 2021b).

Among these funding streams, the most important for our Medicaid analysis is that the aforementioned FFCRA raised the federal matching assistance percentage (FMAP) for the bulk of states' Medicaid expenditures by 6.2 percentage points. This increase, which we discuss at length in the next section, applies for the duration of the formally declared public health crisis.

Finally, state and local governments have incurred increased spending as a result of the pandemic. In the following section, we discuss spending increases in the Medicaid program at length. Other important categories of state and local governments' spending include K-12 and higher education, healthcare and welfare spending outside the Medicaid program, unemployment and retirement benefits, public safety, housing, and utilities. In Clemens et al. (2020) , we estimate that state and local governments may face elevated operating costs from their usual activities on the order of $50 billion for the 2021 fiscal year. The bulk of these costs are linked to the operation of schools for students in grades K-12. This estimate is quite rough and does not include extraordinary public-health and relief spending in direct response to the crisis. This summary of the COVID-19 pandemic's fiscal impacts suggests that, in the aggregate and throughout the current fiscal year, state and local government budgets are unlikely to face unmet fiscal needs. After all, if revenue losses amount to $130 billion, federal aid exceeds $800 billion, and new spending needs for existing programs are around $50 billion, the net change in state and local budget balances is surely positive. The $800 billion in federal aid leaves substantial fiscal space to absorb state and local government exposure to the cost of vaccine distribution and impromptu relief programs for households and businesses. That said, there is, of course, significant heterogeneity across states and localities.

We will now turn to our main contribution, an analysis of developments surrounding the Medicaid program throughout the crisis. In this analysis, we will highlight the sometimes complicated interactions between revenue shocks, spending needs, and intergovernmental transfers, which, as discussed thus far in general terms, are the principal mechanisms through which a downturn affects subnational budgets.

The pandemic's unusually sharp impact on employment has had substantial effects on both eligibility for Medicaid and the availability of employer-provided coverage. In this section, we consider how that has affected state finances and assess the federal government's response.

Specifically, we proceed here in five parts. First, we provide evidence on the magnitudes of the total increase in Medicaid and CHIP enrollment and expenditures. We place these increases in context by contrasting them with changes that occurred during both the Great Recession and the recession of the early 2000s. Second, we discuss aspects of the federal response to COVID-19 that have both increased the Medicaid program's expenditures and increased the extent of federal support. Third, we assess the implications of the pandemic and federal response for states' net exposure to expenditures through the Medicaid and CHIP programs. Fourth, we illustrate the significant heterogeneity across states in Medicaid enrollment increases since the start of the pandemic. Finally, we explore whether federal aid instruments have effectively targeted this dimension of heterogeneity in needs.

Owing to the Medicaid program's income-based eligibility requirements, program enrollment and spending typically follow a countercyclical pattern. As shown in Figure 2 , for example, Medicaid enrollment increased substantially surrounding both the 2001 recession and Great Recession. Note that the large spike in enrollment in 2014 reflects eligibility expansion connected to the Affordable Care Act (ACA).

The baseline nature of Medicaid's countercyclicality has evolved in recent years owing to the ACA's Medicaid expansion for childless adults. In states which adopted the ACA's Medicaid expansion (39 states plus DC), adults with incomes below 138% of the Federal Poverty Level ($17,774 for singles, $36,570 for a family of four in 2021) can qualify for Medicaid coverage (Kaiser Family Foundation, 2020b) . This represented something of a break from the previously categorical nature of eligibility, which generally required that adults have both low incomes and be aged, disabled, or pregnant. The noncategorical nature of the ACA Medicaid expansion should amplify the growth of enrollment in economic downturns.

Unsurprisingly, the economic downturn associated with COVID-19 has resulted in a sharp increase in Medicaid and CHIP enrollment. Using data from the Centers for Medicare and Medicaid Services (CMS), Figure 3 shows that total enrollment across both programs increased by 6.7 million, or 9.4%, from February to September of 2020.

F I G U R E 2 Medicaid enrollment and GDP, annual percent changes, 1995-2018. Note that the Medicaid enrollment data taken are from Medicaid and CHIP Payment and Access Commission (2019). Percent change in seasonally adjusted annual GDP is taken from the United States Bureau of Economic Analysis (2020a) Recent enrollment increases have differed meaningfully across eligibility groups. Figure 4 shows enrollment in Medicaid and CHIP for both adults and children, relative to their levels in February of 2020. Note that income eligibility limits are generally higher for children on Medicaid than adults, and higher still for children covered by CHIP (Kaiser Family Foundation, 2020a). Enrollment was relatively stable leading up to February of 2020; however, Medicaid enrollment has increased markedly since, and most so among adults. In September 2020, child Medicaid enrollment had increased 8.1% since February, while CHIP coverage saw little change (together, child enrollment across Medicaid and CHIP was up 2.3 million, or 6.7%). Over that same period, adult Medicaid enrollment was up 12.1%. The difference between adult and child enrollment growth has been particularly pronounced in expansion states, as depicted in Figure 5 . In expansion states, total adult enrollment grew by roughly 2.2 times as much as child enrollment (11.7% vs. 5.2%). In non-expansion states, adult enrollment outpaced that of children by just 52% (14.2% vs. 9.4%). 4 It is not immediately obvious how these enrollment trends translate to state expenditure needs. Because Medicaid and CHIP are financed jointly by the state and federal governments, the cost of increased enrollment does not fall entirely on the states. States have considerable latitude to design their programs and the federal government "matches" expenditures at a prespecified FMAP. The federal government pays at least 50% of costs, with that share rising for states with lower per-capita incomes. For the fiscal year 2021, the primary matching rates in Medicaid and CHIP averaged 60% and 72%, respectively (Federal Financial Participation in State Assistance Expenditures, 2019). Notably, however, expenditures for the ACA expansion group are matched at the enhanced level of 90%.

The CMS data for 2020 do not separately report enrollment growth for all coverage categories. Given markedly different per-capita expenditures across enrollment groups, this makes it challenging to translate observed enrollment growth into costs for the states and the federal government. Using recent Congressional Budget Office (CBO) reports, however, we can more precisely estimate total program costs associated with anticipated enrollment increases for a near-and medium-term horizon. In particular, the agency estimates that, due to policy changes (discussed in more detail below) and the impact of COVID-19 on the economy, total program enrollment will be nine million higher in 2021 than it had forecast prior to the pandemic (CBO, 2020b). CBO further forecasts that enrollment will remain above the pre-pandemic baseline until 2027. 5 Moreover, enrollment growth is expected to differ meaningfully across categories of beneficiaries. Consistent with the evidence shown above, for example, CBO estimates that enrollment will remain flat in CHIP but increase across Medicaid enrollment categories (CBO, 2020b). Given average expenditures for each group, these enrollment changes imply an additional $59.8 billion in combined state and federal costs in 2021, and $225.6 billion additional costs for 2020-2030. 6 These enrollment and spending increases have the distinct potential to strain state budgets; however, the ultimate burden on states depends heavily on the effects of recent federal legislation. How has the federal response to COVID-19 impacted Medicaid and CHIP?

The FFCRA aided states by increasing the FMAP by 6.2 percentage points for the duration of the public health crisis. Indirectly, this increased CHIP matching rates by roughly 4.3% (Centers for Medicare and Medicaid Services, 2020a). The increased match rate did not directly apply to spending on groups with already enhanced match rates, including the ACA expansion population. Importantly, receipt of the enhanced FMAP was conditional on states maintaining continuous coverage for enrollees, regardless of changes to their eligibility status, for the duration of the health emergency. 7 Further, states were prohibited from tightening eligibility rules or increasing premiums.

The FMAP enhancement and continuous coverage provisions have opposing effects on state expenditures. A higher FMAP delivers pure transfers from the federal government-state financing needs fall one-for-one with each dollar in federal transfers. The continuous coverage provision, however, increases program enrollment and total expenditures. States must still fund their portion of these new program costs. The net effect on state budgets is ambiguous.

The CBO estimates that, together, the Medicaid provisions increased federal spending by $79 billion in 2021 and by $172 billion over the years 2020-2023 (CBO, 2020a). As with prior recessions, this is a substantial portion of total federal spending aimed at states. For example, the American Reinvestment and Recovery Act of 2009 included a similar FMAP enhancement that was in effect from October of 2008 through June of 2011. This increased federal spending by roughly $100 billion (Clemens & Ippolito, 2018; Kaiser Family Foundation, 2011) , 8 which represented a substantial portion of the total $232 billion in grants-in-aid that was transferred to states through the ARRA (United States Bureau of Economic Analysis, 2020b). In the current context, the gross transfers triggered by the Medicaid provisions in the FFCRA exceed the $150 billion allocated to state and local governments through the Coronavirus Relief Fund in the CARES Act. However, the $172 billion in federal spending is not a form of pure budgetary support for the states. To estimate the net budgetary effects, we calculate the transfers and costs associated with the FMAP increase and continuous coverage provision separately. As detailed below, we conclude that a significant share of the fiscal relief owing to the FMAP increase is offset by expenditures linked to the continuous coverage provision.

Let us now parse the effects of the FMAP increase and continuous coverage provision to estimate the net fiscal effect of COVID-related Medicaid legislation. The available data imply that the FMAP increase will transfer about $39 billion to states in 2021, and a total of $89.9 billion from 2020 to 2023. The continuous coverage provision partially offsets this transfer by increasing state expenditures by $20 billion in 2021, and by $41.0 billion for the 2020-2023 4 These results are consistent with our own discussions with a state budget officer in an expansion state. Preliminary data from that state indicated that enrollment growth in the expansion population exceeded that of the non-expansion population from March through September of 2020. Note that expansion states generally have higher income limits for CHIP (Kaiser Family Foundation, 2020a), which complicates an a priori assessment of how relative enrollment patterns are expected to differ across states. 5 For this calculation, we assume zero growth in Medicaid enrollment for those over age 65. 6 This reflects median total expenditures among states that CMS deems to have a high level of data usability. Results are similar if we use estimates from all states. Data are from 2018 (Centers for Medicare and Medicaid Services, 2020a). 7 As observed by Baicker et al. (2012) , the US federal government has a long history of conditioning its intergovernmental transfers on states' compliance with rules that sometimes have substantial costs. period. We conclude that these provisions provided an estimated $18.8 billion in net general fiscal relief to states in 2021, and a total of $43.8 billion for 2020-2023.

These estimates are informed by recent CBO reports. Specifically, the two Medicaid provisions are expected to increase federal expenditures by $41, $79, $47, and $5 billion in 2020, 2021, 2022, and 2023, respectively (CBO, 2020a, tab. A-2). CBO also notes that the FMAP provision accounts for $30 billion in federal spending in 2021 for the population under age 65 (CBO, 2020b) . Scaling by the portion of Medicaid spending attributable to those under 65, we conclude that the FMAP provision is responsible for $38.9 billion in total federal costs for 2021. 9 This implies that federal costs of the two provisions are split nearly evenly in 2021: 49.2% owing to the FMAP increase and 50.8% due to the continuous coverage provision.

CBO's assumption for 2021 provides a useful reference point for allocating federal costs for 2020 through 2023. In 2020, the continuous coverage provision should account for a modest share of federal costs, since the pandemic's negative effects on low-earning households' incomes will limit the continuous coverage provision's bite. Subsequent income growth, however, will increase the continuous coverage provision's impact so long as the public health emergency remains in effect. For our preferred calculations, we assume that the FMAP provision accounts for 75% of federal costs in 2020, roughly 50% in 2021 (as calculated above), 40% in 2022, and 30% in 2023. 10 In aggregate, we assume that the FMAP provision accounts for 52% of federal costs over the 2020-2023 period. This implies a total federal cost of $82 billion for the continuous coverage provision. After adjusting by the average FMAP nationwide (inclusive of the 6.2 percentage point increase), state expenditures owing to the continuous coverage provision are $41.0 billion from 2020 to 2023, and $20.0 billion in 2021. On net, the FMAP and the continuous coverage provisions reduce states' exposure to Medicaid and CHIP expenditures by $43.8 billion over the 4 years during which they are assumed to be in effect. Table 1 summarizes these results.

Legislated transfers via the FMAP increase are projected to outstrip the additional state costs owing to the continuous coverage provision. However, it is not yet clear how these transfers compare to total state Medicaid and CHIP costs owing to the COVID-19 pandemic-costs that stem from both the continuous coverage provision and broader economic decline. As noted above, enrollment increases owing to both of these sources stood to increase total state and federal costs by an estimated $59.8 billion in 2021 and $225.6 billion for 2020-2030 (though, note that costs are assumed to be zero for the last 3 years of this budget window as enrollment returns to baseline). At their normal matching rate for these enrollment categories, state expenditures would have increased by $19.9 billion in 2021 and $84.2 billion for the entire budget window. The FMAP increase offsets these costs by an estimated $38.9 billion in 2021 and $89.9 billion for 2020-2023. On net, federal transfers are projected to effectively offset total state expenditure needs for the Medicaid program over the 2020-2030 window, though somewhat unevenly over time, as shown in Table 2 . Note that federal transfers exceed state expenditure needs through 2022. Enrollment, however, is expected to remain above pre-COVID projections beyond the conclusion of the public health emergency. Because the formal conclusion of the health emergency terminates the FMAP and continuous coverage provisions, the pandemic's long-run effects on enrollment imply a net increase in states' costs after 2022.

Across the entire budget window, federal support is well-matched to expected state Medicaid and CHIP financing needs owing to the COVID-19 pandemic. During the worst portions of 9 Specifically, Medicaid and CHIP Payment and Access Commission (MACPAC) reports that those over the age of 65 account for $94.2 of the $409.3 billion in total Medicaid benefit spending, or 23% (Medicaid and CHIP Payment and Access Commission, 2019). We assume that 23% of enhanced FMAP spending will be spent on enrollees over age 65 in 2021. 10 If we instead assume that the nearly 50/50 split in 2021 is constant across years, we estimate that total net transfers to states for 2020-2023 are a similar $41 billion. However, the distribution across years differs somewhat, with smaller net transfers occurring in 2020, owing to larger costs of the continuous coverage provision and vice versa for 2022/2023. the economic downturn and health crisis, federal transfers overshoot increases in state financing needs for these programs, effectively providing broader fiscal relief. However, federal transfers are expected to expire before economic conditions fully recover, leaving states with elevated financing needs starting in 2023. Given the large amounts of other funding provided by the federal government to state and local governments since the start of the pandemic, this ought not pose insurmountable challenges. In the absence of the ARPA, however, this mismatch might have generated significant uncertainty about state governments' future budgetary and fiscal policy. Uncertainty of this sort can, in its own right, have damaging consequences (Shoag & Veuger, 2016) . We also note that these estimates are themselves uncertain. If the economic recovery is more rapid than expected, Medicaid enrollment may return to baseline more quickly than in CBO's projections, alleviating some of the financing pressures in later years.

The numbers presented so far mask significant cross-state heterogeneity in enrollment increases, spending needs, and federal aid flows. Figures 6 and 7 illustrate this heterogeneity. Figure 6 maps the increase in Medicaid enrollment per state resident from February to September 2020. The increases range from 0.009 to 0.054. Figure 7 breaks the states out into quartiles, ranked according to the percent increase in their number of Medicaid enrollees between February and September 2020. While the bottom-quartile states have seen their Medicaid rolls grow by around 5%, top-quartile states have witnessed a 13% increase.

We now consider the extent to which federal aid has been targeted toward states in which Medicaid enrollments have risen the most dramatically. The biggest source of relief targeted to the needs generated by enrollment shocks is the matching structure of Medicaid itself, which triggers additional federal funds when spending rises to finance enrollment increases (Clemens & Ippolito, 2018) . As Medicaid spending rises, the federal match automatically reduces states' exposure.

In contrast with the basic match, the enhanced FMAP provision delivers the most substantial aid to states with relatively high levels of qualifying expenditures at baseline. Whether this aid targets states that experienced relatively large enrollment shocks is an empirical question. We answer this question in Figure 8 . Through September, growth in Medicaid and CHIP enrollments (and the mechanical growth in federal spending that accompanies it) was positively related to states' unemployment rates and unemployment rate changes, as shown in Figure 8b ,c. Figure 8a , however, shows a weak correlation between Medicaid enrollment increases and Medicaid relief funds delivered through the FFCRA's enhanced FMAP (both expressed on a per capita, or per state resident, basis). We analyze these relationships further in Table 3 . Column 1 confirms that the federal funds from the FFCRA-enhanced FMAP (per capita) do not correlate strongly with enrollment changes per capita. This confirms that the FMAP increase rewards states that had high baseline expenditures rather than states that were more "shocked" by new enrollments. In contrast, Column 2 shows enrollment increases were moderately correlated with unemployment as measured from October to December. Here, the unemployment variable we analyze is constructed using the unemployment data that feed into the state-aid formula legislated through the ARPA. Specifically, we show here that shocks to enrollment per capita correlate positively with the average of October through December unemployment expressed on a per capita basis. In other words, the relief provided through the ARPA is likely to be somewhat helpfully correlated with this dimension of heterogeneity in COVID needs.

Column 3 shows that enrollment shocks, expressed in terms of enrollees per state resident, have been particularly large in ACA expansion states. Note that to the extent that this reflects more strongly countercyclical enrollment among the expansion population itself, this mechanically triggers large transfers in federal funds owing to the 90% federal match for this group. Alternatively, the correlation between enrollment shocks and ACA expansion status may result from expansion states' general approach to administering Medicaid. That is, expansion states may tend to be states with more streamlined enrollment processes, while nonexpansion states may tend to be states with more onerous enrollment processes. Regardless, it is of descriptive interest to note that ACA expansion status predicts the magnitude of pandemic enrollment shocks as strongly-if not more strongly-than some measures of macroeconomic conditions. Recall, for example, that changes in states' unemployment rates quite weakly predict states' enrollment increases, as shown in Figure 8b . The relationship between expansion status and enrollment shocks maintains its magnitude and significance in Column 5, where the enhanced FMAP funds, the ARPA unemployment variable, and expansion status are jointly included in a descriptive multivariate analysis.

The COVID-19 pandemic has affected state and local government budgets by changing revenue streams, raising spending needs, and triggering enormous amounts of federal aid. This paper adds to past work on the pandemic's effects on state and local governments' budgets, and the literature on fiscal federalism more generally, with a detailed look at the Medicaid program.

Our inquiry included two lines of emphasis. First, we investigated the intricate relationship between increased spending needs and additional federal grants in the aggregate. Through the current 10-year budget window and in the aggregate, the additional federal grants roughly cover expected state Medicaid and CHIP financing needs due to the pandemic. While this is true across the budget window, we illustrate the potential relevance of timing. Federal grants overshoot initially and are forecasted to expire before either the economy or Medicaid enrollments have returned to trend. Mistiming of this sort may interact in unintended ways with states' balanced budgeting practices. Interestingly, the duration of the enhanced FMAP is tied to the duration of the public health emergency in a binary fashion. The formal repeal of the public health emergency will thus be a high stakes determination from a state-budgeting perspective. A more gradual phase-out of federal support, perhaps tied to macroeconomic conditions, would reduce this pressure. Our second line of emphasis has been on the heterogeneity in states' experiences. Specifically, we have explored the extent to which federal grants have targeted the states in which Medicaid enrollments rose the most substantially. We show that the enhanced FMAP funds were, in this key respect, ill-targeted; these funds target states with high expenditures at baseline rather than states that have been subject to the largest shocks. In this sense, the enhanced FMAP funds have targeted inframarginal Medicaid spending rather than pandemicinduced increases in Medicaid spending. Interestingly, we show that the American Rescue Plan Act's unemployment-driven formula for allocating unrestricted fiscal assistance better targets aid toward states with large increases in Medicaid and CHIP enrollments.

Going forward, the design of federal fiscal assistance merits additional scrutiny given its role in the American system of fiscal federalism. During both the COVID-19 pandemic and the Great Recession, substantial federal aid has been legislated on an ad hoc basis. The time pressure under which emergency legislative vehicles must be designed may, in turn, risk ill-targeted approaches to dispensing substantial quantities of aid. The design of "automatic stabilizers" for state and local governments may thus be a fruitful area for further analysis.

https://orcid.org/0000-0003-0775-2232

Fiscal Effects of COVID-19

The Rise of the States: US Fiscal Decentralization in the Postwar Period

Families First Coronavirus Response Act-Increased FMAP FAQs

Medicaid and CHIP Enrollment Trends Snapshot through

The Fiscal Effects of the COVID-19 Pandemic on Cities: An Initial Assessment

Does State Fiscal Relief During Recessions Increase Employment? Evidence from the American Recovery and Reinvestment Act

Implications of Medicaid Financing Reform for State Government Budgets

US Fiscal Federalism During the COVID-19 Pandemic

Implications of the Covid-19 Pandemic for State Government Tax Revenues

The COVID-19 Pandemic and the Revenues of State and Local Governments: An Update

State and Local Government Budgets Are in Better Shape than Expected

What's in the Final COVID Relief Deal of 2020

What's in the $1.9 Trillion House COVID Relief Bill

Understanding the $1 Trillion in Unspent COVID Relief Funding

Congressional Budget Office. 2020b. Federal Subsidies for Health Insurance Coverage for People Under

Definitive Adoption (EU, Euratom) 2019/333 of the European Union's general budget for the financial year 2019

Federal Matching Shares for Medicaid, the Children's Health Insurance Program, and Aid to Needy Aged, Blind, or Disabled Persons for

Improving Responsiveness of Federal Assistance to States during Economic Downturns

Impact of the Medicaid Fiscal Relief Provisions in the American Recovery and Reinvestment Act (ARRA)

Medicaid and CHIP Income Eligibility Limits for Children as a Percent of the Federal Poverty Level

Status of State Action on the Medicaid Expansion Decision

Composition of Public Expenditures in the EU. Brussels: Economic Governance Support Unit

Medicaid and CHIP Payment and Access Commission

Uncertainty and the Geography of the Great Recession

Which Taxes Pay for Which State and Local Employees?

Real Gross Domestic Product [A191RL1Q225SBEA]. Retrieved from FRED

Effect of the American Recovery and Reinvestment Act (ARRA) on Federal Government Current Transfer Payments: Grants-In-Aid to State and Local Governments (DISCONTINUED) [GASLGOQ027SBEA]. Retrieved from FRED

All Employees, Local Government [CES9093000001]. Retrieved from FRED

State Government [CES9092000001]. Retrieved from FRED

Estimates of State and Local Government Revenue Losses from Pandemic Mitigation

How Much Help Do State and Local Governments Need? Updated Estimates of Revenue Losses from Pandemic Mitigation